REMIX
Price
$14.41
Change
-$0.08 (-0.55%)
Updated
Oct 7 closing price
Net Assets
745.39M
RLSFX
Price
$15.21
Change
-$0.10 (-0.65%)
Updated
Oct 7 closing price
Net Assets
36.86M
Interact to see
Advertisement

REMIX vs RLSFX

Header iconREMIX vs RLSFX Comparison
Open Charts REMIX vs RLSFXBanner chart's image
Standpoint Multi-Asset Investor
Price$14.41
Change-$0.08 (-0.55%)
VolumeN/A
Net Assets745.39M
RiverPark Long/Short Opportunity Retail
Price$15.21
Change-$0.10 (-0.65%)
VolumeN/A
Net Assets36.86M
REMIX vs RLSFX Comparison Chart in %
View a ticker or compare two or three
VS
REMIX vs. RLSFX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMIX is a Hold and RLSFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REMIX has more cash in the bank: 745M vs. RLSFX (36.9M). REMIX pays higher dividends than RLSFX: REMIX (5.52) vs RLSFX (0.00). REMIX was incepted earlier than RLSFX: REMIX (6 years) vs RLSFX (14 years). RLSFX (2.17) is less costly to investors than REMIX (1.64). RLSFX has a lower initial minimum investment than REMIX: RLSFX (1000) vs REMIX (2500). RLSFX annual gain was more profitable for investors over the last year : 15.46 vs. REMIX (3.33). REMIX return over 5 years is better than : 54.32 vs. RLSFX (-7.83).
REMIXRLSFXREMIX / RLSFX
Total Expense Ratio1.512.0076%
Annual Report Gross Expense Ratio1.642.1776%
Fund Existence6 years14 years-
Gain YTD1.6139.67017%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets745M36.9M2,019%
Annual Yield % from dividends5.520.00-
Returns for 1 year3.3315.4622%
Returns for 3 years14.7879.2719%
Returns for 5 years54.32-7.83-694%
Returns for 10 yearsN/A52.89-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SER5.400.21
+4.05%
Serina Therapeutics
EURKU10.89N/A
N/A
Eureka Acquisition Corp.
HLLY2.95-0.03
-1.01%
Holley
NVCR14.16-0.34
-2.34%
NovoCure Limited
BIO296.52-12.65
-4.09%
Bio-Rad Laboratories IncClass A